Find trials
Search tips

Targeting Inflammation for Endometrial Cancer Prevention

Overview

About this study

The purpose of this study is to develop a unique data and specimen model for a biobank that can be expanded across the Mayo Enterprise and implemented at extramural collaborative sites, including underserved populations.  The targeted demographic will be African American and white women undergoing hysterectomy for benign conditions or endometrial cancer (EC). 

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women over the age of 18 years old undergoing hysterectomy for any benign indication or endometrial cancer.

Exclusion Criteria:

  • Men.
  • Women under the age of 18 years.
  • Women with a history of cancer, except for endometrial cancer or non-melanoma skin cancer.
  • Women with type 1 diabetes.
  • Women that have received radiation or chemotherapy for cancer.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Mark Sherman, M.D.

Closed for enrollment

Contact information:

Mark Sherman M.D.

(904) 953-0771

Sherman.Mark@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Kristina Butler, M.D., M.S.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20523805

Mayo Clinic Footer